Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
XBB.1.5.4EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
XBB.1.5.4EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBB.1.5.4ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-19379.1Germany
XBB.1.5.4ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
XBB.1.5.4EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
XBB.1.5.4EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
XBB.1.5.4ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
XBB.1.5.4ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XBB.1.19.2EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
XBB.1.19.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBB.1.19.2ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-19379.1Germany
XBB.1.19.2ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
XBB.1.19.2EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
XBB.1.19.2EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
XBB.1.19.2ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
XBB.1.19.2ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.479EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
B.1.479EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.479ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-24645.6Germany
B.1.479ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
B.1.479EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
B.1.479EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
B.1.479ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.479ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.437EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
B.1.1.437EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.437ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-24645.6Germany
B.1.1.437ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
B.1.1.437EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
B.1.1.437EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
B.1.1.437ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.1.437ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.371EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
B.1.371EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.371ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-24645.6Germany
B.1.371ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
B.1.371EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
B.1.371EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
B.1.371ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.371ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.4.4EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
B.4.4EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.4.4ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-24645.6Germany
B.4.4ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
B.4.4EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
B.4.4EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
B.4.4ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.4.4ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XBB.1.16.19EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
XBB.1.16.19EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used